These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 29201641)

  • 1. Iron-related gene variants and brain iron in multiple sclerosis and healthy individuals.
    Hagemeier J; Ramanathan M; Schweser F; Dwyer MG; Lin F; Bergsland N; Weinstock-Guttman B; Zivadinov R
    Neuroimage Clin; 2018; 17():530-540. PubMed ID: 29201641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain Iron at Quantitative MRI Is Associated with Disability in Multiple Sclerosis.
    Zivadinov R; Tavazzi E; Bergsland N; Hagemeier J; Lin F; Dwyer MG; Carl E; Kolb C; Hojnacki D; Ramasamy D; Durfee J; Weinstock-Guttman B; Schweser F
    Radiology; 2018 Nov; 289(2):487-496. PubMed ID: 30015589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in the genes coding for iron binding and transporting proteins are associated with disability, severity, and early progression in multiple sclerosis.
    Gemmati D; Zeri G; Orioli E; De Gaetano FE; Salvi F; Bartolomei I; D'Alfonso S; Dall'osso C; Leone MA; Singh AV; Asselta R; Zamboni P
    BMC Med Genet; 2012 Aug; 13():70. PubMed ID: 22883388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the relationship between thalamic iron concentration and disease severity in secondary progressive multiple sclerosis using quantitative susceptibility mapping: Cross-sectional analysis from the MS-STAT2 randomised controlled trial.
    Williams T; John N; Calvi A; Bianchi A; De Angelis F; Doshi A; Wright S; Shatila M; Yiannakas MC; Chowdhury F; Stutters J; Ricciardi A; Prados F; MacManus D; Grussu F; Karsa A; Samson B; Battiston M; Gandini Wheeler-Kingshott CAM; Shmueli K; Ciccarelli O; Barkhof F; Chataway J;
    Neuroimage Rep; 2024 Sep; 4(3):100216. PubMed ID: 39328985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of thalamic magnetic susceptibility in multiple sclerosis indicates decreasing iron with disease duration: A proposed mechanistic relationship between inflammation and oligodendrocyte vitality.
    Schweser F; Raffaini Duarte Martins AL; Hagemeier J; Lin F; Hanspach J; Weinstock-Guttman B; Hametner S; Bergsland N; Dwyer MG; Zivadinov R
    Neuroimage; 2018 Feb; 167():438-452. PubMed ID: 29097315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep gray matter changes in relapsing-remitting multiple sclerosis detected by multi-parametric, high-resolution magnetic resonance imaging (MRI).
    Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
    Eur Radiol; 2021 Feb; 31(2):706-715. PubMed ID: 32851443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron deposition in the gray matter in patients with relapse-remitting multiple sclerosis: A longitudinal study using three-dimensional (3D)-enhanced T2*-weighted angiography (ESWAN).
    Du S; Sah SK; Zeng C; Wang J; Liu Y; Xiong H; Li Y
    Eur J Radiol; 2015 Jul; 84(7):1325-32. PubMed ID: 25959392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Susceptibility Mapping Values Quantification in Deep Gray Matter Structures for Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis.
    Mohammadi S; Ghaderi S; Fatehi F
    Brain Behav; 2024 Oct; 14(10):e70093. PubMed ID: 39415615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human brain atlas for automated region of interest selection in quantitative susceptibility mapping: application to determine iron content in deep gray matter structures.
    Lim IA; Faria AV; Li X; Hsu JT; Airan RD; Mori S; van Zijl PC
    Neuroimage; 2013 Nov; 82():449-69. PubMed ID: 23769915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of deep gray matter magnetic susceptibility over 2 years in multiple sclerosis and healthy control brain.
    Hagemeier J; Zivadinov R; Dwyer MG; Polak P; Bergsland N; Weinstock-Guttman B; Zalis J; Deistung A; Reichenbach JR; Schweser F
    Neuroimage Clin; 2018; 18():1007-1016. PubMed ID: 29868452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
    Wen J; Yablonskiy DA; Luo J; Lancia S; Hildebolt C; Cross AH
    Neuroimage Clin; 2015; 9():164-75. PubMed ID: 27330979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcortical gray matter segmentation and voxel-based analysis using transverse relaxation and quantitative susceptibility mapping with application to multiple sclerosis.
    Cobzas D; Sun H; Walsh AJ; Lebel RM; Blevins G; Wilman AH
    J Magn Reson Imaging; 2015 Dec; 42(6):1601-10. PubMed ID: 25980643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load : A 3-Tesla Magnetic Resonance Imaging Study.
    Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
    Clin Neuroradiol; 2019 Mar; 29(1):51-64. PubMed ID: 29299614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five year iron changes in relapsing-remitting multiple sclerosis deep gray matter compared to healthy controls.
    Elkady AM; Cobzas D; Sun H; Seres P; Blevins G; Wilman AH
    Mult Scler Relat Disord; 2019 Aug; 33():107-115. PubMed ID: 31181540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling the heterogeneous pathological substrates of relapse-onset multiple sclerosis: a multiparametric voxel-wise 3 T MRI study.
    Margoni M; Pagani E; Preziosa P; Gueye M; Azzimonti M; Rocca MA; Filippi M
    J Neurol; 2023 Aug; 270(8):3839-3850. PubMed ID: 37093395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive iron accumulation across multiple sclerosis phenotypes revealed by sparse classification of deep gray matter.
    Elkady AM; Cobzas D; Sun H; Blevins G; Wilman AH
    J Magn Reson Imaging; 2017 Nov; 46(5):1464-1473. PubMed ID: 28301067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of quantitative susceptibility mapping with Perls' iron staining for subcortical gray matter.
    Sun H; Walsh AJ; Lebel RM; Blevins G; Catz I; Lu JQ; Johnson ES; Emery DJ; Warren KG; Wilman AH
    Neuroimage; 2015 Jan; 105():486-92. PubMed ID: 25462797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep Gray Matter Iron Content in Neuromyelitis Optica and Multiple Sclerosis.
    Pudlac A; Burgetova A; Dusek P; Nytrova P; Vaneckova M; Horakova D; Krasensky J; Lambert L
    Biomed Res Int; 2020; 2020():6492786. PubMed ID: 32509866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis: improved identification of disease-relevant changes in gray and white matter by using susceptibility-based MR imaging.
    Rudko DA; Solovey I; Gati JS; Kremenchutzky M; Menon RS
    Radiology; 2014 Sep; 272(3):851-64. PubMed ID: 24828000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contributions of HFE polymorphisms to brain and blood iron load, and their links to cognitive and motor function in healthy adults.
    Kalpouzos G; Mangialasche F; Falahati F; Laukka EJ; Papenberg G
    Neuropsychopharmacol Rep; 2021 Sep; 41(3):393-404. PubMed ID: 34291615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.